Scienture Secures $3.9 Mln Through Registered Direct Stock Offering
(RTTNews) - Scienture Holdings, Inc. (SCNX), a holding company for specialty pharmaceutical businesses, has entered into a securities purchase agreement with institutional investors to sell 3,225,000 shares of common stock at $1.20 per share.
The registered direct offering is expected to raise approximately $3.9 million in gross proceeds before fees and expenses and is scheduled to close on August 15, 2025, subject to customary conditions.
Proceeds will support Scienture's efforts to develop and distribute novel specialty pharmaceutical products targeting unmet market needs.
SCNX currently trades at $1.22 or 45.0450% lower on the NasdaqCM.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.